Autor:	G, Monseu, J, Sternon
Jazyk:	francouzština
Rok vydání:	1999
Předmět:	Indoles Piperidines Sumatriptan Chemistry Pharmaceutical Migraine Disorders Humans Oxazoles Oxazolidinones Tryptamines Serotonin Receptor Agonists
Zdroj:	Revue medicale de Bruxelles. 19(6)
ISSN:	0035-3639
Popis:	One of the outstanding therapeutic revolutions of this last decade has been the introduction of selective serotonin agonists in the acute treatment of migraine. After sumatriptan, introduced in Belgium in 1992, other "triptans" are emerging. The efficacy and the pharmacoeconomic profile of zolmitriptan, the second "triptan" now available in Belgium, are reviewed and the arrival of a third triptan, naratriptan is announced.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::79e424cbfb18faf6024bef65f7572b15 https://pubmed.ncbi.nlm.nih.gov/9916496 Zobrazit plný text záznamu